Viral-associated thrombotic microangiopathies

Hematology/ Oncology and Stem Cell Therapy

Volumn 4, Issue 2, 2011, Pages 51-59

  da Silva, Rodrigo Lopes ^a  

^a HOSPITAL DE SANTO ANTÓNIO DOS CAPUCHOS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADENOVIRUS; ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; BUNYAVIRUS; CALICIVIRUS; CAUSAL ATTRIBUTION; COXSACKIE VIRUS; CRIMEAN CONGO HEMORRHAGIC FEVER; CYTOMEGALOVIRUS; DISEASE PREDISPOSITION; ECHO VIRUS; ENDOTHELIAL DYSFUNCTION; FLAVIVIRUS; GAMMAHERPESVIRINAE; HEMOLYTIC UREMIC SYNDROME; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS; INFLUENZA VIRUS A H1N1; NONHUMAN; ORTHOMYXOVIRUS; PARVOVIRUS; PICORNAVIRUS; POLYOMA VIRUS; REOVIRUS; RETROVIRUS; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VARICELLA ZOSTER VIRUS; VIRUS PATHOGENESIS;

EID: 79961011284     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.5144/1658-3876.2011.51     Document Type: Review

References (118)

1. Moake J. Thrombotic Microangiopathies. N Engl J Med 2002; 347: 589-600.
2. Moake J. Thrombotic microangiopathies: multimers, metalloprotease, and beyond. Clin Transl Sci. 2009; 2: 366-373.
3. Zheng XL, Sadler JE, Zheng XL, Sadler JE. Pathogenesis of Thrombotic Microangiopathies Annu Rev Pathol. 2008; 3: 249-277.
4. Zipfel PF, Heinen S, Skerka C. Thrombotic microangiopathies: new insights and new challenges. Curr Opin Nephrol Hypertens. 2010; 19: 372-378.
5. Richards A, Kavanagh D. Pathogenesis of thrombotic microangiopathy: insights from animal models. Nephron Exp Nephrol. 2009; 113: e97-103.
6. Benz K, Amann K. Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens. 2010; 19: 242-247.
7. Verbeke L, Delforge M, Dierickx D. Current insight into thrombotic thrombocytopenic purpura. Blood Coagul Fibrinolysis. 2010; 21: 3-10.
8. Moake J. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Pract Res Clin Haematol. 2009; 22: 567-576.
9. Tsai HM. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol. 2010; 91: 1-19.
10. Kiss JE. Thrombotic thrombocytopenic purpura: recognition and management. Int J Hematol. 2010; 91: 36-45.
11. Zhou Z, Nguyen TC, Guchhait P, Dong JF. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Thromb Hemost. 2010; 36: 71-81.
12. Lotta LA, Garagiola I, Palla R, Cairo A, Peyvandi F. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura. Hum Mutat. 2010; 31: 11-19.
13. George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). Kidney Int Suppl. 2009: S8-S10.
14. Sánchez-Corral P, Melgosa M. Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome. Br J Haematol. 2010; 150: 529-542.
15. Kavanagh D, Goodship TH. Atypical hemolytic uremic syndrome. Curr Opin Hematol. 2010; 17: 432-438.
16. Kavanagh D, Goodship T. Genetics and complement in atypical HUS. Pediatr Nephrol. 2010; 25: 2431-2442.
17. Hirt-Minkowski P, Dickenmann M, Schifferli JA. Atypical hemolytic uremic syndrome: update on the complement system and what is new. Nephron Clin Pract. 2010; 114: 219-235.
18. Zipfel PF, Mache C, Müller D, Licht C, Wigger M, Skerka C; European DEAP-HUS Study Group. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol. 2010; 25: 2009-2019.
19. Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol. 2011; 26: 41-57.
20. Scheiring J, Rosales A, Zimmerhackl LB. Clinical practice. Today's understanding of the haemolytic uraemic syndrome. Eur J Pediatr. 2010; 169: 7-13.
21. Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 361: 345-357.
22. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008; 358: 1129-1136.
23. Bollée G, Patey N, Cazajous G, Robert C, Goujon JM, Fakhouri F, Bruneval P, Noël LH, Knebelmann B. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib. Nephrol Dial Transplant. 2009; 24: 682-685.
24. Sutor GC, Schmidt RE, Albrecht H. Thrombotic microangiopathies and HIV infection: report of two typical cases, features of HUS and TTP, and review of the literature. Infection. 1999; 27: 12-15.
25. Ahmed S, Siddiqui RK, Siddiqui AK, Zaidi SA, Cervia J. HIV associated thrombotic microangiopathy. Postgrad Med J 2002; 78(923): 520-525.
26. Alpers CE. Light at the end of the TUNEL: HIV-associated thrombotic microangiopathy. Kidney Int. 2003; 63: 385-396.
27. Gomes AM, Ventura A, Almeida C, Correia M, Tavares V, Mota M, Seabra J. Hemolytic uremic syndrome as a primary manifestation of acute human immunodeficiency virus infection. Clin Nephrol. 2009; 71: 563-566.
28. Gervasoni C, Ridolfo AL, Vaccarezza M, Parravicini C, Vago L, Adorni F, Cappelletti A, d'Arminio Monforte A, Galli M. Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis. 2002; 35: 1534-1540.
29. Becker S, Fusco G, Fusco J, Balu R, Gangjee S, Brennan C, Feinberg J; Collaborations in HIV Outcomes Research/US Cohort. Collaborations in HIV Outcomes Research/US Cohort. HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study. Clin Infect Dis 2004; 39(Suppl 5): S267-S275.
30. Tamkus D, Jajeh A, Osafo D, Hadad L, Bhanot B, Yogore MG 3rd. Thrombotic microangiopathy syndrome as an AIDS-defining illness: the experience of J. Stroger Hospital of Cook County. Clin Adv Hematol Oncol. 2006; 4: 145-149.
31. Brecher ME, Hay SN, Park YA. Is it HIV TTP or HIV-associated thrombotic microangiopathy? J Clin Apher. 2008; 23: 186-190.
32. Benjamin M, Terrell DR, Vesely SK, Voskuhl GW, Dezube BJ, Kremer Hovinga JA, Lämmle B, George JN. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009; 48: 1129-1137.
33. Sahud MA, Claster S, Liu L, Ero M, Harris E, Furlan M. von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura. Br J Haematol 2001; 116: 909-911.
34. Gunther K, Garizio D, Nesara P. ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura. Transfusion. 2007; 47: 1710-1716.
35. Malak S, Wolf M, Millot GA, Mariotte E, Veyradier A, Meynard JL, Korach JM, Malot S, Bussel A, Azoulay E, Boulanger E, Galicier L, Devaux E, Eschwège V, Gallien S, Adrie C, Schlemmer B, Rondeau E, Coppo P; Réseau d'Etude des Microangiopathies Thrombotiques (TMA-Rare Diseases Reference Center). Réseau d'Etude des Microangiopathies Thrombotiques (TMA-Rare Diseases Reference Center). Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity. Scand J Immunol. 2008; 68: 337-344.
36. Park YA, Hay SN, Brecher ME. ADAMTS13 activity levels in patients with human immunodeficiency virus-associated thrombotic microangiopathy and profound CD4 deficiency. J Clin Apher. 2009; 24: 32-36.
37. del Arco A, Martinez MA, Peña JM, Gamallo C, González JJ, Barbado FJ, Vazquez JJ. Thrombotic thrombocytopenic purpura associated with human immunode¢ciency virus infection: demonstration of p24 antigen in endothelial cells. Clin Infect Dis 1993; 17: 360-363.
38. Jochimsen F, Gruening W, Arnould T, Segal MS, Kruskall MS, Colgrove R Jr, Walz G. Thrombotic microangiopathy associated with unusual viral sequences in HIV-1-positive patients. Nephrol Dial Transplant 2004; 19: 1129-1135.
39. Ross CL, Hunt BJ, Wyncoll D, Hodgkiss A, Peters B. HIV, thrombotic thrombocytopaenic purpura and rituximab in a violent noncompliant patient. Blood Coagul Fibrinolysis. 2009; 20: 157-160.
40. Evans MW, Vaughan LB, Giffi VS, Zimrin AB, Hess JR. Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases. AIDS Patient Care STDS. 2010; 24: 349-352.
41. Dixon AC, Kwock DW, Nakamura JM, Yanagihara ET, Saiki SM, Bodner AJ, Alexander SS. Thrombotic thrombocytopenic purpura and human T-lymphotrophic virus, type 1 (HTLV-1). Ann Intern Med. 1989; 110: 93-94.
42. Ucar A, Fernandez HF, Byrnes JJ, Lian EC, Harrington WJ Jr. Thrombotic microangiopathy and retroviral infections: a 13-year experience. Am J Hematol. 1994; 45: 304-309.
43. Baid S, Pascual M, Williams WW Jr, Tolkoff-Rubin N, Johnson SM, Collins B, Chung RT, Delmonico FL, Cosimi AB, Colvin RB. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol. 1999; 10: 146-153.
44. Yagita M, Uemura M, Nakamura T, Kunitomi A, Matsumoto M, Fujimura Y. Development of AD-AMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura. J Hepatol. 2005; 42: 420-421.
45. Mak SK, Lo KY, Lo MW, Chan SF, Lo KC, Wong YY, Tong GM, Wong PN, Ma ES, Wong AK. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection. Hong Kong Med J. 2009; 15: 201-208.
46. Tamura S, Sugawara Y, Matsui Y, Kishi Y, Akamatsu N, Kaneko J, Makuuchi M. Thrombotic microangiopathy in living-donor liver transplantation. Transplantation. 2005; 80: 169-175.
47. a by an ADAMTS13 inhibitor in a patient with chronic hepatitis C. Haematologica. 2006 Aug; 91(8 Suppl): ECR34.
48. Deutsch M, Manesis EK, Hadziyannis E, Vassilopoulos D, Archimandritis AJ. Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b. Scand J Gastroenterol. 2007; 42: 408-409.
49. Sallée M, Crétel E, Jean R, Chiche L, Bourlière M, Poullin P, Lefèvre P, Durand JM. Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis. Gastroenterol Clin Biol. 2008; 32: 145-146.
50. Yamazaki S, Takayama T, Inoue K, Higaki T, Makuuchi M. Transplantation-related thrombotic microangiopathy triggered by preemptive therapy for hepatitis C virus infection. Transplantation. 2008; 86: 1010-1011.
51. Iyoda K, Kato M, Nakagawa T, Kakiuchi Y, Sugiyasu Y, Fujii E, Fujimoto K, Michida T, Kaneko A, Hayashi N, Yamamoto K, Kurosawa K, Ikeda M, Masuzawa M. Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C. J Gastroenterol. 1998; 33: 588-592.
52. a and ribavirine in a patient with chronic hepatitis C. Presse Med. 2010; 39: 1207-1210.
53. Wiersinga WJ, Scheepstra CG, Kasanardjo JS, de Vries PJ, Zaaijer H, Geerlings SE. Dengue fever-induced hemolytic uremic syndrome. Clin Infect Dis. 2006; 43: 800-801.
54. Rossi FC, Angerami RN, de Paula EV, Orsi FL, Shang D, del Guercio VM, Resende MR, Annichino-Bizzacchi JM, da Silva LJ, Zheng XL, Castro V. A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection. Transfusion. 2010; 50: 208-212.
55. Klisnick A, Soriano C, Gazuy N, Forestier C, Peigue-Lafeuille H. Rotavirus infection associated with adult thrombotic microangiopathy. Presse Med. 1999; 28: 1287-1289.
56. Bendall RP, Gray JJ. Haemorrhagic colitis and haemolytic-uraemic syndrome: false positive reaction with a rotavirus latex agglutination test. J Clin Pathol. 1991; 44: 609-610.
57. Sugimoto T, Ogawa N, Aoyama M, Sakaguchi M, Isshiki K, Kanasaki M, Uzu T, Nishio Y, Eguchi Y, Kashiwagi A. Haemolytic uraemic syndrome complicated with norovirus-associated gastroenteritis. Nephrol Dial Transplant. 2007; 22: 2098-2099.
58. Ardalan MR, Tubbs RS, Chinikar S, Shoja MM. Crimean-Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure. Nephrol Dial Transplant. 2006; 21: 2304-2307.
59. Cronin CM, Fennell JS, McKiernan J, Murnaghan DJ. Haemolytic-uraemic syndrome associated with hepatitis A virus infection. Ir Med J. 1983; 76: 357.
60. Glasgow LA, Balduzzi P. Isolation of Coxsackie virus group A, type 4, from a patient with hemolytic-uremic syndrome. N Engl J Med. 1965; 273: 754-756.
61. Ray CG, Portman JN, Stamm SJ, Hickman RO. Hemolytic-uremic syndrome and myocarditis. Association with coxsackievirus B infection. Am J Dis Child. 1971; 122: 418-420.
62. Austin TW, Ray CG. Coxsackie virus group B infections and the hemolytic-uremic syndrome. J Infect Dis. 1973; 127: 698-701.
63. Vecilla MC, Ruiz Moreno M, Bernacer M, Casado S, Rocandio L. Familial hemolytic-uremic syndrome associated with Coxsackie B infection. An Esp Pediatr. 1984; 20: 369-374.
64. O'Regan S, Robitaille P, Mongeau JG, McLaughlin B. The hemolytic uremic syndrome associated with ECHO 22 infection. Clin Pediatr (Phila). 1980; 19: 125-127.
65. Larke RP, Preiksaitis JK, Devine RD, Harley FL. Haemolytic uraemic syndrome: evidence of multiple viral infections in a cluster of ten cases. J Med Virol. 1983; 12: 51-59.
66. Burch GE, Tsui C Y, Harb JM. Pathologic changes of aorta and coronary arteries of mice infected with coxsackie B4 virus. Proc. Soc. Exp. Biol. Med. 1971; 137: 657-661.
67. De Petris L, Gianviti A, Caione D, Innocenzi D, Edefonti A, Montini G, De Palo T, Tozzi AE, Caprioli A, Rizzoni G. Role of non-polio enterovirus infection in pediatric hemolytic uremic syndrome. Pediatr Nephrol. 2002; 17: 852-855.
68. Kosugi N, Tsurutani Y, Isonishi A, Hori Y, Matsumoto M, Fujimura Y. Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor. Intern Med. 2010; 49: 689-693.
69. Brodin-Sartorius A, Guebre-Egziabher F, Fouque D, Cozon G, Villar E, Laville M, Juillard L. Recurrent idiopathic thrombotic thrombocytopenic purpura: A role of vaccination in disease relapse? Am J Kidney Disease 2006; 48: e31-e34.
70. Dias PJ, Gopal S. Refractory thrombotic thrombocytopenic purpura following influenza vaccination. Anaesthesia 2009; 64: 444-446.
71. Wang T-T, Palese P. Universal epitopes of influenza virus hemagglutinins? Nature Struc Mol Biol 2009; 16: 233-234.
72. Bento D, Mapril J, Rocha C, Marchbank KJ, Kavanagh D, Barge D, Strain L, Goodship TH, Meneses-Oliveira C. Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1). Ren Fail. 2010; 32: 753-756.
73. Trachtman H, Sethna C, Epstein R, D'Souza M, Rubin LG, Ginocchio CC. Atypical hemolytic uremic syndrome associated with H1N1 influenza A virus infection. Pediatr Nephrol. 2011; 26: 145-146.
74. Caltik A, Akyüz SG, Erdogan O, Demircin G. Hemolytic uremic syndrome triggered with a new pandemic virus: influenza A (H1N1). Pediatr Nephrol. 2011; 26: 147-148.
75. Allen U, Licht C. Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger? Pediatr Nephrol. 2011; 26: 3-5.
76. Printza N, Roilides E, Kotsiou M, Zafeiriou D, Hatzidimitriou V, Papachristou F. Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome. Pediatr Nephrol. 2011; 26: 143-144.
77. Golubovic E, Miljkovic P, Zivic S, Jovancic D, Kostic G. Hemolytic uremic syndrome associated with novel influenza A H1N1 infection. Pediatr Nephrol. 2011; 26: 149-150.
78. Lei TH, Hsia SH, Wu CT, Lin JJ. Streptococcus pneumoniae-associated haemolytic uremic syndrome following influenza A virus infection. Eur J Pediatr. 2010; 169: 237-239.
79. Asaka M, Ishikawa I, Nakazawa T, Tomosugi N, Yuri T, Suzuki K. Hemolytic uremic syndrome associated with influenza A virus infection in an adult renal allograft recipient: case report and review of the literature. Nephron. 2000; 84: 258-266.
80. Watanabe T. Hemolytic uremic syndrome associated with influenza A virus infection. Nephron. 2001; 89: 359-360.
81. Sharman VL, Goodwin FJ. Hemolytic uremic syndrome following chicken pox. Clin Nephrol. 1980; 14: 49-51.
82. Kwon T, Belot A, Ranchin B, Baudouin V, Fremeaux-Bacchi V, Dragon-Durey MA, Cochat P, Loirat C. Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases. Nephrol Dial Transplant. 2009; 24: 2752-2754.
83. Cavagnaro F, Barriga F. Hemolytic uremic syndrome in a child with leukemia and cytomegalovirus infection. Pediatr Nephrol. 2000; 14: 1118-1120.
84. Catón B, Díaz de Otazu R, Aldamiz-Echebarria M, Viguri A. Haemolytic-uraemic syndrome with thrombotic microangiopathy of the retina following cytomegalovirus infection: postmortem findings. Postgrad Med J. 1993; 69: 653-655.
85. Neau D, Bonnet F, Viallard JF, Longy-Boursier M, Le Bras M. Thrombotic thrombocytopenic purpura and cytomegalovirus infection in an immunocompetent adult. Clin Infect Dis. 1997; 25: 1495-1496.
86. Maslo C, Peraldi MN, Desenclos JC, Mougenot B, Cywiner-Golenzer C, Chatelet FP, Jacomet C, Rondeau E, Rozenbaum W, Sraer JD. Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. Clinic. Infect. Dis. 1997; 24, 3, 350-355.
87. Rerolle JP, Canaud G, Fakhouri F, Aaron L, Morelon E, Peraldi MN, Kreis H, Bruneel MF. Thrombotic microangiopathy and hypothermia in an HIV-positive patient: importance of cytomegalovirus infection. Scand. J. Infect. Dis. 2004; 36, 3, 234-237.
88. Francisci D, Marroni M, Morosi S, Canovari B, Belfiori B, Stagni G, Baldelli F. Fatal haemolytic uraemic syndrome in an AIDS patient with disseminated adenovirus and cytomegalovirus coinfection. Infez Med. 2006; 14: 37-40.
89. Esteve V, Reynaga E, de las Cuevas X. Cytomegalovirus infection-associated thrombotic microangiopathy as the first clinical manifestation of HIV primary infection. Nefrologia. 2006; 26: 639-641.
90. Ramasubbu K, Mullick T, Koo A, Hussein M, Henderson JM, Mullen KD, Avery RK. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl. Infect. Dis. 2003; 5: 98-103.
91. Jeejeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy. Transplantation 1998; 65: 1645-1648.
92. Waiser J, Budde K, Rudolph B, Ortner MA, Neumayer HH. De novo haemolytic uraemic syndrome postrenal transplant after cytomegalovirus infection. Am. J. Kidney Dis. 1999; 34, 3, 556-559.
93. Karthikeyan V, Parasuraman R, Shah V, Vera E, Venkat KK. Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation. Am J Transplant 2003; 3: 1289-1294.
94. Olie KH, Goodship TH, Verlaak R, Florquin S, Groothoff JW, Strain L, Weening JJ, Davin JC. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir. Am J Kidney Dis. 2005; 45: e12-15.
95. Noël C, Saunier P, Hazzan M, Pruvot FR, Dracon M, Jude B, Lelièvre G. Incidence and clinical profile of microvascular complications in renal allografted patients treated with cyclosporine. Ann Med Interne 1992; 143(suppl 1): 33-36.
96. De Keyzer K, Van Laecke S, Peeters P, Vanholder R. De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss. Am J Nephrol. 2010; 32: 491-496.
97. Hasegawa D, Sano K, Kosaka Y, Hayakawa A, Kawagoe R, Amo K, Taya K, Hirabayashi N, Nakamura H. Infantile T cell acute lymphoblastic leukemia complicated by thrombotic microangiopathy and human herpes virus 6 infection after allogeneic peripheral blood stem cell transplantation using CD34-positive cells. Rinsho Ketsueki. 1999; 40: 574-580.
98. Matsuda Y, Hara J, Miyoshi H, Osugi Y, Fujisaki H, Takai K, Ohta H, Tanaka-Taya K, Yamanishi K, Okada S. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children. Bone Marrow Transplant. 1999; 24: 919-923.
99. Belford A, Myles O, Magill A, Wang J, Myhand RC, Waselenko JK. Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation. Am J Hematol. 2004; 76: 156-162.
100. Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, Okamoto T, Kanamaru A, Kakishita E. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant. 2003; 31: 475-479.
101. Shashaty GG, Atamer MA. Hemolytic uremic syndrome associated with infectious mononucleosis. Am J Dis Child. 1974; 127: 720-722.
102. Lee MH, Cho KS, Kahng KW, Kang CM. A case of hemolytic uremic syndrome associated with Epstein-Barr virus infection. Korean J Intern Med. 1998; 13: 131-135.
103. Simonetti GD, Dumont-Dos Santos K, Pachlopnik JM, Ramelli G, Bianchetti MG. Hemolytic uremic syndrome linked to infectious mononucleosis. Pediatr Nephrol. 2003; 18: 1193-1194.
104. Watanabe T. Hemolytic uremic syndrome associated with Epstein-Barr virus infection. Pediatr Nephrol. 2004; 19: 569.
105. Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, Dezube BJ. HIV/AIDS: epidemiology, pathophysiology, and treatment of kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis 2008; 47: 1209-1215.
106. Goodman DJ, von Alberini MA, McShea A, Wrighton CJ, Bach FH. Adenoviral-mediated over-expression of I(kappa)B(alpha) in endothelial cells inhibits natural killer cell-mediated endothelial cell activation. Transplantation 1996; 62: 967-972.
107. Fassas AB, Buddharaju LN, Rapoport A, Cottler-Fox M, Drachenberg C, Meisenberg B, Tricot G. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogenic bone marrow transplantation. Leuk. Lymphoma. 2001; 42: 801-804.
108. Kok RH, Wolfhagen MJ, Klosters G. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection. Clin Infect Dis. 2001; 32: 311-312.
109. Seward EW, Rustom R, Nye FJ, Bone JM. Haemolytic-uraemic syndrome following human parvovirus infection in a previously fit adult. Nephrol Dial Transplant. 1999; 14: 2472-2473.
110. Murer L, Zacchello G, Bianchi D, Dall'Amico R, Montini G, Andreetta B, Perini M, Dossi EC, Zanon G, Zacchello F. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol. 2000; 11: 1132-1137.
111. Härtel C, Herz A, Vieth S, Lensing C, Schultz C. Renal complications associated with human parvovirus B19 infection in early childhood. Klin Padiatr. 2007; 219: 74-75.
112. Ardalan MR, Shoja MM, Tubbs RS, Esmaili H, Keyvani H. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection. Am J Transplant. 2008; 8: 1340-1344.
113. Orimo K, Ukeba Y, Koseki N, Saita Y, Kobayashi I. Prolonged anemia by superinfection of parvovirus B19 in a boy with enterohemorrhagic Escherichia coli 0157-associated hemolytic uremic syndrome. Eur J Pediatr. 2009; 168: 501-502.
114. Ardalan MR, Shoja MM, Tubbs RS, Jayne D. Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis. Exp Clin Transplant. 2008; 6: 137-143.
115. Lopes da Silva R, Ferreira I, Teixeira G, Cordeiro D, Mafra M, Costa I, Bravo Marques JM, Abecasis M. BK virus encephalitis with thrombotic microangiopathy in an allogeneic hematopoietic stem cell transplant recipient. Transpl Infect Dis. 2011; 13: 161-167.
116. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, Koralnik IJ, Dvorak AM, Monahan-Earley R, DE Girolami PC, DE Girolami U, Upton M, Major EO, Pfister LA, Joseph JT. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med. 2001; 345: 1250-1255.
117. Baid S, Pascual M, Cosimi AB, Chung RT, Colvin RB, Tolkoj-Rubin N. Viruses and thrombotic microangiopathy. Transplantation 1999; 68: 710-711.
118. Afzal F, Budisavljevic MN, Rajagopalan PR, Baliga PK. Viruses in posttransplant thrombotic microangiopathy. Transplantation 2001; 72: 750.